1st Allergy and Clinical Research Center

Centennial, Colorado CO 80112

0 studies enrolling now · 5 studies all time

What they study most

Acute, Uncomplicated Human Influenza, Asthma, Eosinophilic Esophagitis, Immunologic Deficiency Syndromes

Studies at this site

• Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis — Completed
• Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years — Completed
• A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza — Completed
• A Clinical Study of Intravenous Immunoglobulin — Completed
• Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation. — Completed